CPS Announces Second Quarter 2014 Earnings Pretax

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CPS Announces Second Quarter 2014 Earnings
  • Pretax income of $12.3 million
  • Net income of $7.0 million, or $0.22 per diluted share
  • New contract purchases of $211 million
  • Total managed portfolio increases to $1.374 billion from $1.295 billion at March 31, 2014
  • Second quarter ABS earns triple "A" rating.

IRVINE, Calif., July 21, 2014 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS ) ("CPS" or the "Company") today announced earnings of $7.0 million, or $0.22 per diluted share, for its second quarter ended June 30, 2014. This compares to net income of $4.8 million, or $0.15 per diluted share, in the second quarter of 2013, representing a 47% increase in earnings per diluted share. Earnings for the first six months of 2014 were $13.7 million, or $0.43 per diluted share, as compared to earnings of $8.6 million, or $0.27 per diluted share, for the same period in 2013.

Revenues for the second quarter of 2014 were $71.6 million, an increase of $1.1 million, or 1.6%, compared to $70.5 million for the second quarter of 2013. However, in the second quarter of 2013, revenues included $10.9 million from a gain on cancellation of debt. Excluding that gain, revenues for the second quarter of 2014 increased by $12.1 million, or 20.3%. Total operating expenses for the second quarter of 2014 were $59.3 million, a decrease of $2.7 million, or 4.3%, compared to $61.9 million for the 2013 period. However, in the second quarter of 2013, operating expenses included a provision for contingent liabilities of $9.7 million. Excluding the provision for contingent liabilities, operating expenses increased $7.0 million, or 13.3%. Pretax income for the second quarter of 2014 was $12.3 million compared to pretax income of $8.5 million in the second quarter of 2013, an increase of 44.3%.

For the six months ended June 30, 2014 total revenues were $139.7 million compared to $114.1 million for the six months ended June 30, 2013, excluding the gain from the cancellation of debt, an increase of approximately $25.6 million, or 22.4%. Total expenses for the six months ended June 30, 2014 were $115.6 million, an increase of $15.3 million, or 15.2%, compared to $100.3 million for the six months ended June 30, 2013, excluding the provision for contingent liabilities in that period. Pretax income for the six months ended June 30, 2014 was $24.1 million, compared to $15.1 million for the six months ended June 30, 2013.

During the second quarter of 2014, CPS purchased $211.4 million of new contracts compared to $189.9 million during the first quarter of 2014 and $203.8 million during the second quarter of 2013. The Company's managed receivables totaled $1.374 billion as of June 30, 2014, an increase from $1.295 billion as of March 31, 2014 and $1.067 billion as of June 30, 2013, as follows ($ in millions):

Originating Entity June 30, 2014 March 31, 2014 June 30, 2013
CPS $1,366.6 $1,282.6 $1,030.5
Fireside Bank 5.7 9.1 31.1
As Third Party Servicer  1.3 3.5 5.8
Total $1,373.6 $1,295.2 $1,067.4

Annualized net charge-offs for the second quarter of 2014 were 4.98% of the average owned portfolio as compared to 4.03% for the second quarter of 2013.  Delinquencies greater than 30 days (including repossession inventory) were 6.21% of the total owned portfolio as of June 30, 2014, as compared to 5.16% as of June 30, 2013.

As previously reported, during June CPS closed its second term securitization transaction of 2014 and the 13 th transaction since April 2011. In the senior subordinate structure, a special purpose subsidiary sold five tranches of asset-backed notes totaling $202.5 million. The notes are secured by automobile receivables purchased by CPS and have a weighted average effective coupon of approximately 2.37%. The transaction has initial credit enhancement consisting of a cash deposit equal to 1.00% of the original receivable pool balance. The final enhancement level requires accelerated payment of principal on the notes to reach overcollateralization of 4.00% of the then-outstanding receivable pool balance. The transaction was CPS's first senior subordinate securitization to receive a triple "A" rating on the senior class of notes.

"We are pleased with our operating results for the second quarter of 2014," said Charles E. Bradley, Jr., Chairman and Chief Executive Officer. "We increased our new contract purchases and managed portfolio, and achieved continued earnings growth. In addition, we hit a milestone in one of our corporate objectives by earning a triple 'A' rating on the senior class of notes in our 2014-B securitization, which contributed to an extremely low cost of funds on that transaction."

Conference Call

CPS announced that it will hold a conference call on Tuesday, July 22, 2014, at 1:00 p.m. ET to discuss its quarterly operating results.  Those wishing to participate by telephone may dial-in at 877 312-5502 or 253 237-1131 approximately 10 minutes prior to the scheduled time.

A replay of the conference call will be available between July 22, 2014 and July 29, 2014, beginning two hours after conclusion of the call, by dialing 855 859-2056 or 404 537-3406 for international participants, with conference identification number 76956813. A broadcast of the conference call will also be available live and for 90 days after the call via the Company's web site at www.consumerportfolio.com .

About Consumer Portfolio Services, Inc.

Consumer Portfolio Services, Inc. is an independent specialty finance company that provides indirect automobile financing to individuals with past credit problems, low incomes or limited credit histories. We purchase retail installment sales contracts primarily from franchised automobile dealerships secured by late model used vehicles and, to a lesser extent, new vehicles. We fund these contract purchases on a long-term basis primarily through the securitization markets and service the contracts over their lives.

Forward-looking statements in this news release include the Company's recorded revenue, expense and provision for credit losses, because these items are dependent on the Company's estimates of incurred losses. The accuracy of such estimates may be adversely affected by various factors, which include (in addition to risks relating to the economy generally) the following: possible increased delinquencies; repossessions and losses on retail installment contracts; incorrect prepayment speed and/or discount rate assumptions; possible unavailability of qualified personnel, which could adversely affect the Company's ability to service its portfolio; possible increases in the rate of consumer bankruptcy filings, which could adversely affect the Company's rights to collect payments from its portfolio; other changes in government regulations affecting consumer credit; possible declines in the market price for used vehicles, which could adversely affect the Company's realization upon repossessed vehicles; and economic conditions in geographic areas in which the Company's business is concentrated. All of such factors also may affect the Company's future financial results, as to which there can be no assurance. Any implication that the results of the most recently completed quarter are indicative of future results is disclaimed, and the reader should draw no such inference. Factors such as those identified above in relation to the provision for credit losses may affect future performance.

Consumer Portfolio Services, Inc. and Subsidiaries    
Condensed Consolidated Statements of Operations    
(In thousands, except per share data)    
(Unaudited)    
         
   Three months ended 
June 30, 
 Six months ended
June 30, 
  2014 2013 2014 2013
Revenues:        
Interest income  $ 68,221  $ 55,797  $ 133,217  $ 106,964
Servicing fees  367  876  880  1,784
Other income  3,006  2,862  5,643  5,380
Gain on cancellation of debt  --   10,947  --   10,947
   71,594  70,482  139,740  125,075
Expenses:        
Employee costs  11,774  11,527  22,664  20,476
General and administrative  5,075  4,518  8,678  8,272
Interest  11,942  14,601  25,323  30,947
Provision for credit losses  25,627  17,371  49,508  32,519
Provision for contingent liabilities  --   9,650  --   9,650
Other expenses  4,847  4,269  9,474  8,137
   59,265  61,936  115,647  110,001
Income before income taxes  12,329  8,546  24,093  15,074
Income tax expense  5,303  3,721  10,362  6,464
 Net income   $ 7,026  $ 4,825  $ 13,731  $ 8,610
         
Earnings per share:        
Basic  $ 0.28  $ 0.23  $ 0.56  $ 0.42
Diluted  $ 0.22  $ 0.15  $ 0.43  $ 0.27
         
Number of shares used in computing earnings per share:        
Basic 25,029 20,989 24,694 20,534
Diluted 32,002 31,788 32,009 31,709
         
         
Condensed Consolidated Balance Sheets    
(In thousands)    
(Unaudited)    
         
  June 30,
2014
December 31,
2013
   
Assets:        
Cash and cash equivalents  $ 14,426  $ 22,112    
Restricted cash and equivalents 154,902 132,284    
Total cash and cash equivalents 169,328 154,396    
         
Finance receivables 1,312,745 1,155,063    
Allowance for finance credit losses (53,326) (39,626)    
Finance receivables, net 1,259,419 1,115,437    
         
Finance receivables measured at fair value 5,686 14,476    
Residual interest in securitizations 260 854    
Deferred tax assets, net 51,550 59,215    
Other assets 54,831 51,988    
   $ 1,541,074  $ 1,396,366    
         
Liabilities and Shareholders' Equity:        
Accounts payable and accrued expenses  $ 24,252  $ 24,839    
Warehouse lines of credit 41,290 9,452    
Residual interest financing 14,079 19,096    
Debt secured by receivables measured at fair value 5,392 13,117    
Securitization trust debt 1,326,319 1,177,559    
Senior secured debt, related party -- 38,559    
Subordinated renewable notes 18,038 19,142    
  1,429,370 1,301,764    
         
Shareholders' equity 111,704 94,602    
   $ 1,541,074  $ 1,396,366    
                 
Operating and Performance Data ($ in millions)                
                 
   At and for the 
Three months ended
June 30, 
  At and for the
Six months ended
June 30, 
 
  2014   2013   2014   2013  
                 
Contracts purchased  $ 211.38    $ 203.78    $ 401.27    $ 383.90  
Contracts securitized  200.21    209.64    374.80    370.90  
                 
Total managed portfolio  $ 1,373.58    $ 1,067.42    $ 1,373.58    $ 1,067.42  
Average managed portfolio  1,343.46    1,034.57    1,309.13    989.31  
                 
Allowance for finance credit losses as % of fin. receivables 4.06%   3.30%          
                 
Aggregate allowance as % of fin. receivables (1) 5.19%   4.02%          
                 
Delinquencies                
31+ Days 4.10%   3.82%          
Repossession Inventory 2.11%   1.34%          
Total Delinquencies and Repo. Inventory 6.21%   5.16%          
                 
Annualized net charge-offs as % of average owned portfolio 4.98%   4.03%   5.25%   4.12%  
                 
Recovery rates (2) 49.2%   48.6%   48.6%   48.8%  
                 
  For the 
Three months ended 
June 30, 
 For the 
Six months ended 
June 30, 
  2014 2013 2014 2013
  $ (3) % (4) $ (3) % (4) $ (3) % (4) $ (3) % (4)
Interest income  $ 68.22 20.3%  $ 55.80 21.6%  $ 133.22 20.4%  $ 106.96 21.6%
Servicing fees and other income  3.37 1.0%  3.74 1.4%  6.52 1.0%  7.16 1.4%
Interest expense  (11.94) -3.6%  (14.60) -5.6%  (25.32) -3.9%  (30.95) -6.3%
Net interest margin   59.65 17.8%  44.93 17.4%  114.42 17.5%  83.18 16.8%
Provision for credit losses  (25.63) -7.6%  (17.37) -6.7%  (49.51) -7.6%  (32.52) -6.6%
Risk adjusted margin  34.03 10.1%  27.56 10.7%  64.91 9.9%  50.66 10.2%
Core operating expenses  (21.70) -6.5%  (20.31) -7.9%  (40.82) -6.2%  (36.89) -7.5%
Provision for contingent liabilities  --  0.0%  (9.65) -3.7%  --  0.0%  (9.65) -2.0%
Gain on cancellation of debt  --  0.0%  10.95 4.2%  --  0.0%  10.95 2.2%
Pre-tax income  $ 12.33 3.7%  $ 8.55 3.3%  $ 24.09 3.7%  $ 15.07 3.0%
                 
(1) Includes allowance for finance credit losses and allowance for repossession inventory.          
(2) Wholesale auction liquidation amounts (net of expenses) for CPS portfolio as a percentage of the account balance at the time of sale.
(3) Numbers may not add due to rounding.                
(4) Annualized percentage of the average managed portfolio. Percentages may not add due to rounding.      

Investor Relations Contact Jeffrey P. Fritz, Chief Financial Officer 844 878-2777

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading